SHARx, LLC.

SHARx, LLC. SHARx (pronounced “sharks”) was designed to serve the uninsured and underinsured populations that are struggling to afford lifesaving medications.

SHARx removes barriers and helps ensure affordable access to high-cost maintenance & specialty medications. https://linktr.ee/sharxllc

CFOs don’t just want explanations for rising healthcare costs; they want the confidence that comes from strategic resour...
04/14/2026

CFOs don’t just want explanations for rising healthcare costs; they want the confidence that comes from strategic resource allocation. To move from a renewal vendor to a trusted advisor, brokers must look beyond trend percentages and expose the actual incentives driving the spend. This clarity is essential for any broker looking to manage financial risk rather than just a spreadsheet.

To earn a seat at the table, you must quantify volatility and frame inaction as a choice with real consequences. Proactively addressing emerging risks turns a pharmacy "black box" into a manageable, high-impact asset. Read our latest blog to learn more: https://sharxplan.com/the-5-questions-every-cfo-will-ask-and-how-brokers-should-answer-them/

04/02/2026

'𝐎𝐧 𝐭𝐡𝐞 𝐑𝐚𝐝𝐚𝐫' | 18th Edition is live!

The pharmacy landscape isn’t just evolving. It’s being rebuilt in real time.

This week’s edition breaks down the forces reshaping employer health plans:
• A shift toward high-value, tightly focused drug pipelines
• Continued pressure from patent protections and limited competition
• Rising premiums putting strain on the employer-sponsored model
• Federal reforms driving PBM transparency and pricing restructuring
• Increasing expectations around fiduciary oversight and accountability

At the same time, healthcare spending is approaching 20% of the U.S. economy, and concern over drug costs remains high.

Check out the eighteenth edition: 🔗 https://sharxplan.com/on-the-radar-18th-edition/

Meet Christina Krupp - Christina has made a strong impact in a short amount of time. She has approached the role with a ...
04/01/2026

Meet Christina Krupp -

Christina has made a strong impact in a short amount of time. She has approached the role with a great attitude, a willingness to learn, and the initiative to ask thoughtful questions to better understand both the work and the team.

Christina has picked up processes quickly and has already shown a strong level of ownership in her responsibilities, which has helped her build confidence and trust with both the team and our partners. Christina’s communication, responsiveness, and attention to detail have stood out, especially as she continues to take on more responsibility.

It’s been great to see the progress she has made so far, and her continued growth will be a strong asset to both the Account Management team and the organization.

Thank you, Christina!

🎙️The 𝗥𝗶𝘀𝗶𝗻𝗴 𝗧𝗶𝗱𝗲𝘀 podcast, hosted by SHARx CEO and sports enthusiast Corey Durbin, invites listeners into the inner cir...
03/27/2026

🎙️The 𝗥𝗶𝘀𝗶𝗻𝗴 𝗧𝗶𝗱𝗲𝘀 podcast, hosted by SHARx CEO and sports enthusiast Corey Durbin, invites listeners into the inner circle of influential athletes to explore the grit and determination required to achieve sports stardom. These candid conversations dive deep into the personal aspirations and trials of elite competitors, offering a unique perspective on the intersection of professional success and personal resilience. By highlighting these powerful stories, the show aims to inspire a community, the Rising Tides Army, that is ready to tackle systemic challenges both on and off the field.

Beyond the highlights, this platform serves as a rallying cry to expose the staggering reality of the pharmaceutical industry and advocate for affordable medication for all. With brand drugs in the U.S. costing an average of 422% more than in other countries, the Rising Tides Army is challenging the status quo to drive meaningful change for employers and individuals alike.

Join the mission to transform the healthcare landscape, spark necessary conversations, and ensure that essential, lifesaving medicines are accessible to everyone who needs them.

03/20/2026

'𝐎𝐧 𝐭𝐡𝐞 𝐑𝐚𝐝𝐚𝐫' | 17th Edition is live!

The conversation is shifting from list price to real price and it’s changing everything.

This week’s edition dives into the forces redefining pharmacy strategy for employers:
- Why net price is the only number that actually matters
- The growing wave of ERISA litigation tied to pharmacy spend
- How PBM transparency and contracting models are evolving
- What federal pricing actions mean for drug cost stability
- Why specialty drugs are reshaping benefit design decisions

The theme is clear: visibility is increasing, and so is accountability.

Employers who understand their true pharmacy costs and actively manage them will be in a much stronger position moving forward.

Check out the seventeenth edition: 🔗 https://sharxplan.com/on-the-radar-17th-edition/

We are hiring for an Advocate to champion member needs, a Business Analyst to drive data-driven strategies, a Regional S...
03/09/2026

We are hiring for an Advocate to champion member needs, a Business Analyst to drive data-driven strategies, a Regional Sales Director to lead our market expansion, and a Senior Software Engineer to help build the next generation of healthcare technology. If you are passionate about bringing transparency to the industry and want to work in a culture that values innovation and human-centric solutions, we want to hear from you.

Join us as we continue to lower prescription costs and reclaim control over the healthcare journey for employers and members alike. https://sharxplan.com/careers/

03/06/2026

'𝐎𝐧 𝐭𝐡𝐞 𝐑𝐚𝐝𝐚𝐫' | 16th Edition is live!

Pharmacy transparency is no longer theoretical. It’s becoming operational.

This week’s edition covers the forces reshaping employer health plans, including:
• Federal PBM reforms requiring 100% rebate pass-through
• New DOL fee disclosure rules targeting hidden PBM compensation
• Why healthcare prices, not utilization, drive U.S. spending
• The unintended costs emerging from the No Surprises Act arbitration system
• The growing debate around drug pricing, OTC access, and pharmaceutical advertising

Across policy, pricing, and plan design, one theme continues to surface: visibility is replacing opacity in the prescription drug supply chain.

Check out the sixteenth edition: https://sharxplan.com/on-the-radar-16th-edition/

Meet Corinne Stevens -Corinne provides outstanding contributions to our financial analytics. She consistently steps up t...
03/06/2026

Meet Corinne Stevens -

Corinne provides outstanding contributions to our financial analytics. She consistently steps up to take on complex challenges, approaches each day with intention, and demonstrates exceptional initiative and timeliness.

Her collaborative spirit and openness to feedback strengthen the entire team and elevate our performance, enabling SHARx to make confident, data-driven financial decisions. Her impact is both clear and deeply appreciated.

Thank you, Corinne!

02/20/2026

Patent cliffs. Federal PBM reform. Mandatory rebate pass-through. DOL audit rights. Super Bowl GLP-1 ads. Pharmacy is moving from opaque to exposed at record speed.

This edition covers:
• How “evergreening” keeps drug prices elevated
• Why U.S. healthcare remains the most expensive globally
• What the new federal PBM legislation really requires
• How fee disclosure rules could trigger ERISA litigation
• Why employers must rethink high-cost drug coverage strategy

The throughline is clear: transparency is no longer optional. Governance is becoming non-negotiable.

Read the full recap: https://sharxplan.com/on-the-radar-15th-edition/

SHARx has a vision of healthcare that works for everyone. We believe the main stakeholders, each U.S. household, should ...
02/19/2026

SHARx has a vision of healthcare that works for everyone. We believe the main stakeholders, each U.S. household, should have a seat at the table and not be suffocated by a system profiting on their lack of influence.

As a team of people deeply committed to this cause, it was a distinct privilege to spend time with Sophie Cunningham. Just as she has boldly done for her teammates, she is helping SHARx fight for fair and affordable access for all Americans.

Thank you, Sophie!
https://www.youtube.com/watch?v=vPmpKhV8SIA





Stop settling for vague quarterly reports that blame "market pressure" for your rising costs. Your pharmacy spend is lik...
02/17/2026

Stop settling for vague quarterly reports that blame "market pressure" for your rising costs. Your pharmacy spend is likely a tangled web of ingredient costs, hidden rebates, and specialty pharmacy economics that rarely flow in a straight line. If you only see the totals, you’re missing the actual mechanics whether your formulary is optimized for your savings or your PBM’s rebate yield.

Transparency alone isn't a strategy; you need the context to understand which decisions are actually driving your increases. Read our latest blog to find out how to turn that "black box" into a strategic lever that protects your health plan's long-term sustainability: https://sharxplan.com/decoding-your-pharmacy-spend-where-your-dollars-are-really-going/

Today, we honor the legacy of leadership that built our nation. Happy Presidents’ Day!
02/16/2026

Today, we honor the legacy of leadership that built our nation. Happy Presidents’ Day!

Address

635 Maryville Center Drive
St. Louis, MO
63141

Opening Hours

Monday 8am - 5pm
Tuesday 8am - 5pm
Wednesday 8am - 5pm
Thursday 8am - 5pm
Friday 8am - 5pm

Telephone

+13144513555

Website

https://www.sharxplan.com/, https://www.linkedin.com/company/sharx-llc/

Alerts

Be the first to know and let us send you an email when SHARx, LLC. posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Shortcuts

Share

Share on Facebook Share on Twitter Share on LinkedIn
Share on Pinterest Share on Reddit Share via Email
Share on WhatsApp Share on Instagram Share on Telegram

Category